IP Library › Granted Patent US 10,876,105
Granted Patent B2
US 10,876,105 · App. 16/190,402 · Granted Dec 29, 2020

Methods for extracellular vesicle isolation and selective removal

Inventor: Yousef Haj-Ahmad (St. Catharines, CA)
Assignee: Norgen Biotek Corp.
C12N15/1006C12N15/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,876,105
App. No.
16/190,402
Granted
Dec 29, 2020
Kind
B2
Abstract

Disclosed is a method for the isolation of extracellular vesicles, including exosomes, from a liquid sample, the method comprising the steps of: adjusting the pH of a liquid sample comprising extracellular vesicles to a preselected, binding pH; contacting the liquid sample with silicon carbide, wherein at the preselected, binding pH, the extracellular vesicles bind to the silicon carbide; and eluting the bound extracellular vesicles from the silicon carbide. The liquid samples can comprise bodily fluids. Further disclosed is a method for producing a liquid sample, substantially depleted of extracellular vesicles, including exosomes.

Claims (14)

1. A method for producing a liquid sample substantially depleted of extracellular vesicles, the method comprising the steps of:

(a) adjusting the pH of a liquid sample comprising extracellular vesicles to a preselected, binding pH;

(b) contacting the liquid sample with silicon carbide, wherein at the preselected, binding pH, the extracellular vesicles bind to the silicon carbide;

(c) separating the silicon carbide with the bound extracellular vesicles from the liquid sample to yield a liquid substantially depleted of extracellular vesicles; and

(d) collecting the liquid substantially depleted of extracellular vesicles.

2. The method of claim 1 , wherein the extracellular vesicles comprise exosomes.

3. The method of claim 1 , wherein the liquid sample comprises a serum.

4. The method of claims 1 , wherein the silicon carbide is in a slurry format or the silicon carbide is packed into a solid support column.

5. The method of claim 4 , wherein the silicon carbide is a slurry format and wherein step (b) occurs before step (a), such that a liquid sample is contacted with the silicon carbide before the pH of the liquid sample is adjusted to the preselected binding pH to affect binding of the extracellular vesicles to the silicon carbide.

6. The method of claims 4 , wherein the silicon carbide is a slurry format and wherein the silicon carbide is removed from the liquid sample by centrifugation or by gravity settling.

7. The method of claim 1 , wherein the preselected, binding pH is about 2 to about 4.

8. The method of claim 7 , wherein the preselected, binding pH is about 3.

9. The method of claim 1 , wherein the preselected, binding pH is about 7 to about 11.

10. The method of claim 9 , wherein the preselected, binding pH is about 8.5.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2018
From: HAJ-AHMAD, YOUSEF
To: NORGEN BIOTEK CORP.
Reel/Frame 047793/0607 →
Continuity (3)
Division 15147969 · May 6, 2016
Provisional Application 62160647 · May 13, 2015
Related Publication 20190078078A1 · Mar 14, 2019
Cited By (1)
US 1,101,143